Publications

Detailed Information

Genetic variation of IL13 as a risk factor of reduced lung function in children and adolescents: A cross-sectional population-based study in Korea

DC Field Value Language
dc.contributor.authorPark, Heung-Woo-
dc.contributor.authorLee, Jong-Eun-
dc.contributor.authorKim, Se-Hoon-
dc.contributor.authorKim, Yoon-Keun-
dc.contributor.authorKim, You-Young-
dc.contributor.authorCho, Sang-Heon-
dc.contributor.authorMin, Kyung-Up-
dc.date.accessioned2012-05-25T01:41:09Z-
dc.date.available2012-05-25T01:41:09Z-
dc.date.issued2009-02-
dc.identifier.citationRESPIRATORY MEDICINE; Vol.103 2; 284-288ko_KR
dc.identifier.issn0954-6111-
dc.identifier.urihttps://hdl.handle.net/10371/76449-
dc.description.abstractBackground: Previous investigations have suggested that genetic variations are associated with reduced lung function in early childhood. This study was conducted to evaluate the association between IL13 + 2044G -> A, the functionally relevant single nucleotide polymorphism (SNP) in the gene coding IL13, and lung function in early childhood. Patients and methods: A total of 1900 subjects aged 10-18 years living in Korea, were randomly recruited. Lung function test and methacholine bronchial provocation test were performed. Multiple regression analysis adjusting for sex, age, height, atopy, and history of passive smoking was done to evaluate effect of IL13 + 2044G -> A on lung function. Results: Mean (SD) forced expiratory volume in 1s (FEV(1)) was 2.66 L (+/- 0.60) in subjects with the AA or AG genotype (n = 982) and 2.75 L (+/- 0.57) in subjects with the GG genotype In = 918). IL13 + 2044G -> A showed a significant association with FEV(1) [in the minor allele dominant model (GG vs. AG + AA), P < 0.001]. Interestingly, the association between FEV(1) and IL13 + 2044G -> A remained still significant in subgroup analysis according to the presence of AHR (P < 0.001 in subjects without AHR and P = 0.002 in subjects with AHR). Moreover, FEV(1)/FVC (forced vital. capacity) ratio also showed a significant association with IL13 + 2044G -> A in both groups (P < 0.001 in subjects without AHR and P < 0.001 in subjects with AHR). This cross-sectional study demonstrates that IL13 + 2044G -> A is significantly associated with a reduced lung function in Korean children and adolescents. (C) 2008 Elsevier Ltd. All rights reserved.ko_KR
dc.description.sponsorshipThis work was supported by the Korea Health 21 R&D Project Grant 03-PJ10-PG13-GD01-0002 and the Clinical Research Center for
Chronic Obstructive Airway Disease Grant 0412-CR03-0704-0001from the Korean Ministry of Health and Welfare.
ko_KR
dc.language.isoenko_KR
dc.publisherElsevierko_KR
dc.subjectLung functionko_KR
dc.subjectIL13ko_KR
dc.subjectPolymorphismko_KR
dc.subjectChildrenko_KR
dc.titleGenetic variation of IL13 as a risk factor of reduced lung function in children and adolescents: A cross-sectional population-based study in Koreako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박흥우-
dc.contributor.AlternativeAuthor이종은-
dc.contributor.AlternativeAuthor김세훈-
dc.contributor.AlternativeAuthor김윤근-
dc.contributor.AlternativeAuthor민경업-
dc.contributor.AlternativeAuthor김유영-
dc.contributor.AlternativeAuthor조상헌-
dc.identifier.doi10.1016/j.rmed.2008.08.009-
dc.citation.journaltitleRESPIRATORY MEDICINE-
dc.description.citedreferenceSadeghnejad A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-2-
dc.description.citedreferenceLeung TF, 2007, CLIN EXP ALLERGY, V37, P1480, DOI 10.1111/j.1365-2222.2007.02799.x-
dc.description.citedreferenceStern DA, 2007, LANCET, V370, P758-
dc.description.citedreferenceKim JJ, 2007, EUR ARCH OTO-RHINO-L, V264, P395, DOI 10.1007/s00405-006-0204-x-
dc.description.citedreferencePark HW, 2006, J ALLERGY CLIN IMMUN, V117, P774, DOI 10.1016/j.jaci.2005.12.1328-
dc.description.citedreferenceOber C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284-
dc.description.citedreferenceKim HB, 2006, J HUM GENET, V51, P1055, DOI 10.1007/s10038-006-0061-x-
dc.description.citedreferenceSimpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC-
dc.description.citedreferenceVladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818-
dc.description.citedreferenceHegab AE, 2004, CHEST, V126, P1832-
dc.description.citedreferenceChen WG, 2004, J ALLERGY CLIN IMMUN, V114, P553, DOI 10.1016/j.jaci.2004.04.044-
dc.description.citedreferenceKhoo SK, 2004, J ALLERGY CLIN IMMUN, V113, P475, DOI 10.1016/j.jaci.2003.10.043-
dc.description.citedreferenceHan W, 2004, CLIN CANCER RES, V10, P124-
dc.description.citedreferenceJakubzick C, 2004, IMMUNOL RES, V30, P339-
dc.description.citedreferenceElias JA, 2003, CHEST, V123, p339S-
dc.description.citedreferenceHe JQ, 2003, AM J RESP CELL MOL, V28, P379, DOI 10.1165/rcmb.4885-
dc.description.citedreferenceKraan TCTMV, 2002, GENES IMMUN, V3, P436-
dc.description.citedreferenceBelperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-00089OC-
dc.description.citedreferenceKim YK, 2002, CLIN EXP ALLERGY, V32, P1305, DOI 10.1046/j.1365-2745.2002.01478.x-
dc.description.citedreferenceKumar RK, 2002, CLIN EXP ALLERGY, V32, P1104-
dc.description.citedreferenceRasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009-
dc.description.citedreferenceZhu Z, 2001, AM J RESP CRIT CARE, V164, pS67-
dc.description.citedreferenceGrol MH, 1999, AM J RESP CRIT CARE, V160, P1830-
dc.description.citedreferenceULICK CS, 1999, AM J RESP CRIT CARE, V160, P40-
dc.description.citedreference1993, EUR RESP J, V16, P1-
dc.description.citedreferenceSHERRILL D, 1992, PEDIATR PULM, V13, P78-
dc.description.citedreferencePEAT JK, 1991, AM REV RESPIR DIS, V144, P663-
dc.description.citedreferenceREDLINE S, 1989, AM REV RESPIR DIS, V140, P179-
dc.description.tc3-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share